Related references
Note: Only part of the references are listed.Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families
Patrizia Noris et al.
BLOOD (2011)
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias
Carlo L. Balduini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Analysis of 12,517 inhabitants of a Sardinian geographic isolate reveals that predispositions to thrombocytopenia and thrombocytosis are inherited traits
Ginevra Biino et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Molecular determinants dictating cell surface expression of the human sodium-dependent vitamin C transporter-2 in human liver cells
Veedamali S. Subramanian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Heavy chain myosin 9-related disease (MYH9-RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder
Anna Savoia et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families
Paolo Gresele et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease
Alessandro Pecci et al.
HUMAN MUTATION (2008)
Description of a novel mutation leading to MYH9-related disease
Rachel A. Burt et al.
THROMBOSIS RESEARCH (2008)
Liver tetraploidization is controlled by a new process of incomplete cytokinesis
Germain Margall-Ducos et al.
JOURNAL OF CELL SCIENCE (2007)
Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells
Hilde Herrema et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-Darby canine kidney cells
W Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A single class II myosin modulates T cell motility and stopping, but not synapse formation
J Jacobelli et al.
NATURE IMMUNOLOGY (2004)
Extracellular matrix-dependent myosin dynamics during G1-S phase cell cycle progression in hepatocytes
K Bhadriraju et al.
EXPERIMENTAL CELL RESEARCH (2004)
Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: Association of subcellular localization with MYH9 mutations
S Kunishima et al.
LABORATORY INVESTIGATION (2003)
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders
A Pecci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes
M D'Apolito et al.
GENE (2002)
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes
KE Heath et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Archival, demographic and genetic studies define a Sardinian sub-isolate as a suitable model for mapping complex traits
A Angius et al.
HUMAN GENETICS (2001)
Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome
A Savoia et al.
BLOOD (2001)
Myosins: a diverse superfamily
JR Sellers
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly
MJ Kelley et al.
NATURE GENETICS (2000)
Share Paper
